Therapeutic Biotechnology (22,667 companies)
9,141 Companies
Access all companiesSpotfolio tracks over one million companies in technology industries.
There are 9,141 companies in the field of Biotechnology on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Drug, Therapeutic, Research, Patients, Disease, Scientific, Cell .
Start-ups (1,316)
Early-stage companies (2,004)
Established companies (4,755)
The majority of these companies is located in the following countries.
United States (4,838)
United Kingdom (547)
Canada (345)
Germany (339)
Example Companies
Find companies in your areaAccess
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
CANNA-THERAPEUTIC - R & D - PARTNERS - WHO WE ARE - NEWS - Search Archive for year: 2020 You are here: Home / Blog / 2020 Canna Therapeutic versus ...
versus Canndoc Canna Therapeutic versus Canndoc January 31, 2020/0 Comments/in Uncategorized /by Jeppe Søe Canna Therapeutic indgår historisk aftale om ...
om årlig produktion af 30 ton medicinsk cannabis: Canna Therapeutic i Stenløse indgår rekordstor aftale med det israelske selskab CannDoc, der sikrer den ...
0 0 Jeppe Søe Jeppe Søe2020-01-31 10:33:172020-01-31 10:38:16Canna Therapeutic versus Canndoc Followon TwitterSubscribeto RSS Feed Latest news Categories
- CANNA-THERAPEUTIC - R & D - PARTNERS - WHO WE ARE - NEWS - Search Archive for month: January, 2020 You are here: Home / Blog / 2020 / January ...
Canna Therapeutic versus Canndoc Canna Therapeutic versus Canndoc January 31, 2020/0 Comments/in Uncategorized /by Jeppe Søe Canna Therapeutic indgår ...
historisk aftale om årlig produktion af 30 ton medicinsk cannabis: Canna Therapeutic i Stenløse indgår rekordstor aftale med det israelske selskab CannDoc ...
0 0 Jeppe Søe Jeppe Søe2020-01-31 10:33:172020-01-31 10:38:16Canna Therapeutic versus Canndoc Followon TwitterSubscribeto RSS Feed Latest news Categories
Therapeutic Innovations

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
Advisors Products Airbaby Media News/Blog Gallery Contact Therapeutic Innovations 07.13.18 Therapeutic Innovations' founder featured in Northeastern University's ...
article] 04.13.17 Therapeutic Innovations presents research at RISE 2017 [click on photo link for article] View fullsize Therapeutic Innovations engineer ...
the Airbaby to NASA's Mr. Eric McGill. Click for article. 10.27.17 Therapeutic Innovations' founder gets featured in Alumni magazine [click on photo ...
Mensah, co-founder and entrepreneurial lead of Therapeutic Innovations. Click for article. 10.06.16 Therapeutic Innovations wins second place at PLUG Cambridge
Advisors Products Airbaby Media News/Blog Gallery Contact Therapeutic Innovations Scroll THERAPEUTIC INNOVATIONS A Medical Technology Company kEEPING BABIES ...
life more bearable. Hope fills the chasm between bad and good times. At Therapeutic Innovations we believe that where there is hope, there is a way. HEALTH ...
hope and good health comes quality life. Recent News NEWS Feature Therapeutic Innovations CEO gets feature article in Northeastern University online
Therapeutic Peptides

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
contact Therapeutic Peptides, Inc. 7053 Revenue Drive Baton Rouge, LA 70809 phone 225.753-3990 fax 225.752.4751 info@tpipeptides.com © Therapeutic Peptides
Bioactivity - applications - contact app.html app.html app.html read more. Therapeutic Peptides® patented oligopeptide technology platform provides enhanced ...
first generation linear cationic helical oligopeptides. Development Therapeutic Peptides, Inc. ("TPI") is a premier and prolific developer of peptide ...
peptides and lipopeptides are available exclusively through Symrise, Inc. © Therapeutic Peptides, Inc. 2015
Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
About Us - Looking Forward COVID-19 AIT Strategies Advanced Immune Therapeutic Strategies (AIT Strategies) is a biomedical firm specializing in translational ...
organizations to facilitate development of novel therapies in cancer and other therapeutic areas. Dr. Christopher Nicodemus “If you prevent something from happening ...
clinical immunology) You have reached the home page of Advanced Immune Therapeutic Strategies -- AIT Strategies Immune complexes processed by dendritic
COVID-19 - Home - About Us - Looking Forward COVID-19 Advanced Immune Therapeutic Strategies (AIT Strategies) is a privately held firm focusing on biomedical ...
seeking innovative solutions. Several main areas of focus are noted: - Therapeutic IgE for Cancer. From the original development at Advanced Immune Therapeutics ...
promise as a third generation strategy for the treatment of cancer. - Therapeutic IgG for Cancer. Monoclonal specific IgG of select isotypes can serve as ...
immunizers with select chemotherapeutics and other immune modulators creates therapeutic windows allowing synergistic effect. Efforts focus on schedule dependent ...
clinically practical agents that have the potential to meaningfully enhance therapeutic outcomes of cancer specific immunotherapy. Several publications in this
Morphic Therapeutic Morphic Holding, LLC

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
Morphic Therapeutic to Present at the Jefferies Next Generation IBD Therapeutics Virtual Summit September 21, 2020 WALTHAM, Mass., Sept. 21, 2020 (GLOBE ...
(GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the ...
the company’s website following the conference. About Morphic Therapeutic Morphic Therapeutic is a biopharmaceutical company developing a new generation of ...
integrin structure and biology. For more information, visit Contacts Morphic Therapeutic Chris Erdman chris.erdman@morphictx.com 617.686.1718 Media Contact Tom
PhD, Morphic Therapeutic Waltham MA USA 14 February 2020 Disclosures • Jamie Wong is a paid employee and shareholder of Morphic Therapeutic. ©ECCO‘20 Vienna ...
Vienna Congress - Speaker: Jamie Wong, Morphic Therapeutic Inhibition of α4β7 is a clinically validated mechanism for IBD Vascular space - blood T-cell ...
therapy in IBD ©ECCO‘20 Vienna Congress - Speaker: Jamie Wong, Morphic Therapeutic MORF-057 demonstrates high selectivity for α4β7 • MORF-057 has more than ...
respectively ©ECCO‘20 Vienna Congress - Speaker: Jamie Wong, Morphic Therapeutic MORF-057 inhibits gut homing leukocytes in mice Peyer's Patches mLN ...
antibody treatment ©ECCO‘20 Vienna Congress - Speaker: Jamie Wong, Morphic Therapeutic 30 0. 30 1 3 0. pk 3m ve h ic le 0.0 10 200 pk 3m 400 ic ...
homing in monkeys ©ECCO‘20 Vienna Congress - Speaker: Jamie Wong, Morphic Therapeutic Conclusions • Vedolizumab is a safe and effective therapy for Ulcerative
Topics
Search by any topicOnly spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.
Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.
The following topics addressed by the majority of companies help you discover major players in the field.
- Antibody
- Assay
- Biology
- Biopharmaceutical
- Biotech
- Biotechnology
- Blood
- Chief
- Clinical-Development
- Clinical-Trials
- Commercialization
- Dose
- Drug-Development
- Drug-Discovery
- Efficacy
- FDA
- Gene
- Genetic
- Immune
- Immunology
- Inflammatory
- Life-Science
- Molecular
- Molecules
- Oncology
- PhD
- Phase
- Preclinical
- Professor
- Protein
- Receptor
- Therapy
- Translational
- Trials
- Tumor
- Unmet
- Vitro
- Vivo
All companies in this field address the following more general topics.
Use Cases
Register nowTechnology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.
Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.